Loading...
XHKG2211
Market cap19mUSD
Dec 23, Last price  
0.19HKD
1D
15.24%
Jan 2017
-94.68%
IPO
-99.26%
Name

Universal Health International Group Holding Ltd

Chart & Performance

D1W1MN
XHKG:2211 chart
P/E
344.50
P/S
0.13
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
16.64%
Rev. gr., 5y
-17.12%
Revenues
1.09b
-25.46%
2,326,292,0003,323,499,0004,355,842,0004,805,855,0003,378,719,0002,645,939,3232,785,486,4271,673,889,5631,387,860,3531,539,676,0281,461,063,0821,089,037,000
Net income
413k
P
213,760,000355,103,000472,724,00031,163,000-87,811,000-611,338,306-305,189,362-544,694,748-790,905,028-226,854,537-118,725,822413,000
CFO
-102m
L+424.29%
161,628,000386,948,000592,015,00046,263,00035,295,000-122,510,728-351,312,044-449,521,560-124,669,573-47,814,906-19,404,451-101,735,000
Dividend
Sep 17, 20150.015 HKD/sh

Profile

Universal Health International Group Holding Limited, an investment holding company, engages in the distribution, wholesale, and retail of drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, prepackaged foods, nutritional foods, health care products, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; dairy products comprise infant formula milk powder; etc. The company also provides storage services. It serves pharmaceutical retailers, hospitals, clinics, and distributors. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015. Universal Health International Group Holding Limited was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.
IPO date
Dec 12, 2013
Employees
3,007
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062016‑122015‑122014‑12
Income
Revenues
1,089,037
-25.46%
1,461,063
-5.11%
1,539,676
10.94%
Cost of revenue
1,114,751
1,541,579
1,704,706
Unusual Expense (Income)
NOPBT
(25,714)
(80,516)
(165,030)
NOPBT Margin
Operating Taxes
(3,372)
(6,748)
1,522
Tax Rate
NOPAT
(22,342)
(73,768)
(166,552)
Net income
413
-100.35%
(118,726)
-47.66%
(226,855)
-71.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,812
13,034
24,050
BB yield
-20.10%
-20.32%
-35.51%
Debt
Debt current
30,300
49,689
34,677
Long-term debt
40,300
43,487
46,887
Deferred revenue
Other long-term liabilities
334
Net debt
(64,290)
(71,183)
(138,648)
Cash flow
Cash from operating activities
(101,735)
(19,404)
(47,815)
CAPEX
(69)
(122)
Cash from investing activities
54,884
461
4,813
Cash from financing activities
40,233
12,695
67,656
FCF
120,862
(27,283)
(35,682)
Balance
Cash
36,925
89,365
103,484
Long term investments
97,965
74,994
116,728
Excess cash
80,438
91,306
143,229
Stockholders' equity
352,885
(1,634,810)
(1,661,524)
Invested Capital
343,047
2,067,521
2,222,171
ROIC
ROCE
EV
Common stock shares outstanding
668,644
583,115
439,825
Price
0.07
-33.64%
0.11
-28.57%
0.15
-16.76%
Market cap
48,811
-23.90%
64,143
-5.30%
67,733
-5.23%
EV
(15,312)
(7,040)
(70,236)
EBITDA
(11,684)
(62,227)
(133,531)
EV/EBITDA
1.31
0.11
0.53
Interest
1,356
1,701
1,596
Interest/NOPBT